Tolerx

Monoclonal antibody for the treatment of autoimmune type 1 diabetes

placeCambridge, Massachusetts, United States calendar_todayFounded 2000 groups13 employees language tolerx.com

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital2100%
Coming soon